Anti-SARS-CoV-2 equine F (Ab′)2 immunoglobulin as a possible therapy for COVID-19 (2022)
Source: Scientific Reports. Unidade: ICB
Subjects: MICROBIOLOGIA, COVID-19, IMUNOGLOBULINAS, HAMSTERS, PLASMA DE ANIMAL, MODELOS ANIMAIS DE DOENÇAS, CORONAVIRUS, PLASMA, ANTÍGENOS DE VÍRUS, ENSAIO CLÍNICO
ABNT
BOTOSSO, Viviane Fongaro et al. Anti-SARS-CoV-2 equine F (Ab′)2 immunoglobulin as a possible therapy for COVID-19. Scientific Reports, v. 12, p. 1-17, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-07793-1. Acesso em: 18 ago. 2024.APA
Botosso, V. F., Jorge, S. A. C., Astray, R. M., Guimarães, A. M. de S., Mathor, M. B., Carneiro, P. dos S. de, et al. (2022). Anti-SARS-CoV-2 equine F (Ab′)2 immunoglobulin as a possible therapy for COVID-19. Scientific Reports, 12, 1-17. doi:10.1038/s41598-022-07793-1NLM
Botosso VF, Jorge SAC, Astray RM, Guimarães AM de S, Mathor MB, Carneiro P dos S de, Durigon EL, Covas D, Durigon DBL de O. Anti-SARS-CoV-2 equine F (Ab′)2 immunoglobulin as a possible therapy for COVID-19 [Internet]. Scientific Reports. 2022 ; 12 1-17.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1038/s41598-022-07793-1Vancouver
Botosso VF, Jorge SAC, Astray RM, Guimarães AM de S, Mathor MB, Carneiro P dos S de, Durigon EL, Covas D, Durigon DBL de O. Anti-SARS-CoV-2 equine F (Ab′)2 immunoglobulin as a possible therapy for COVID-19 [Internet]. Scientific Reports. 2022 ; 12 1-17.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1038/s41598-022-07793-1